Intercept Pharmaceuticals, Inc.
ICPT · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $102,736 | $136,229 | $61,404 | $50,517 |
| Short-Term Investments | $219,978 | $277,630 | $372,191 | $435,049 |
| Receivables | $32,479 | $29,792 | $28,745 | $26,862 |
| Inventory | $2,649 | $6,272 | $6,461 | $0 |
| Other Curr. Assets | $27,332 | $20,846 | $21,656 | $22,356 |
| Total Curr. Assets | $383,445 | $470,769 | $490,457 | $540,127 |
| Property Plant & Equip (Net) | $822 | $906 | $899 | $987 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8,895 | $12,960 | $12,729 | $12,597 |
| Total NC Assets | $9,717 | $13,866 | $13,628 | $13,584 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $393,162 | $484,635 | $504,085 | $553,711 |
| Liabilities | – | – | – | – |
| Payables | $10,267 | $85 | $12,744 | $14,234 |
| Short-Term Debt | $0 | $109,808 | $109,688 | $109,569 |
| Tax Payable | $2,868 | $2,370 | $3,204 | $3,144 |
| Deferred Revenue | $0 | -$85 | $0 | $0 |
| Other Curr. Liab. | $80,578 | $77,214 | $84,685 | $106,274 |
| Total Curr. Liab. | $90,845 | $187,022 | $207,117 | $230,077 |
| LT Debt | $223,856 | $223,603 | $223,352 | $223,104 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6,616 | $6,464 | $6,431 | $7,453 |
| Total NC Liab. | $230,472 | $230,067 | $229,783 | $230,557 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $321,317 | $417,089 | $436,900 | $460,634 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $42 | $42 | $42 | $42 |
| Retained Earnings | -$2,177,675 | -$2,174,885 | -$2,169,023 | -$2,136,888 |
| AOCI | -$7,203 | -$7,619 | -$7,623 | -$8,256 |
| Other Equity | $2,256,681 | $2,250,008 | $2,243,789 | $2,238,179 |
| Total Equity | $71,845 | $67,546 | $67,185 | $93,077 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $393,162 | $484,635 | $504,085 | $553,711 |
| Net Debt | $121,120 | $197,182 | $271,636 | $282,156 |